$200.00
Otezla® (apremilast) 30 mg Tablets – Bottle of 30 Tablets
Product Description:
Otezla® is a prescription medication that contains apremilast, a phosphodiesterase 4 (PDE4) inhibitor, used to treat psoriasis, psoriatic arthritis, and Behçet’s disease. Apremilast works by inhibiting the PDE4 enzyme, which plays a role in inflammation. By reducing the production of certain inflammatory molecules, Otezla helps to manage the symptoms of these chronic conditions, including the reduction of plaques and lesions in psoriasis and the improvement of joint function in psoriatic arthritis. Otezla offers an effective, oral treatment option with minimal systemic side effects.
Product Features:
Active Ingredient: Apremilast
Strength: 30 mg per tablet
Dosage Form: Oral tablet
Quantity: Bottle of 30 tablets
Administration: Taken once daily, typically with or without food (dosage may be adjusted based on the patient’s condition)
Indications:
Psoriasis: Treatment of moderate to severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy
Psoriatic Arthritis: Treatment of active psoriatic arthritis, either alone or in combination with other disease-modifying antirheumatic drugs (DMARDs)
Behçet’s Disease: Treatment of oral ulcers associated with Behçet’s disease in adults
Reviews
There are no reviews yet.